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The hypothesis that the glucocorticoid hormone receptor interacts with RNA has been tested in cultured 
rat hepatoma cells. The receptor was covalentIy labeled with radioactive dexamethasone mesylate, and puta- 
tive RNA-receptor complexes were stabilized by either cell-free crosslinking using formaldehyde or irradia- 
tion of intact cells. After chemical cross-linking in vitro, the receptor displayed the buoyant density of a 
ribonucleoprotein in CsCl gradients. After photochemical crosslinking in cells labeled with radioactive uri- 
dine, the receptor analysed by polyacrylamide gel electrophoresis was carrying labeled ribonucleotides. 
Glucocorticoid Receptor Affinity labeling Ribonucleoprotein Crosslinking 
1. INTRODUCTION 
Glucocorticoid hormones control the expression 
of a small number of transcriptionally active genes 
by increasing or decreasing mRNA concentration 
(review [l]). This results from a glucocorticoid 
receptor-mediated change in the rate of transcrip- 
tion and (or) in mRNA stability. The receptor is an 
intracellular oligomeric phosphoprotein. Binding 
of the hormone promotes dissociation and 
presumably dephosphorylation of the receptor 
subunits, a process called ‘transformation’. The 
transformed receptor binds to chromatin where it 
can interact with defined DNA regions, thereby 
controlling gene expression by unknown 
mechanisms. Cell-free receptor transformation is 
stimulated by high ionic strength and by 
temperature and is blocked by molybdate ions. 
Transformation can be assessed in vitro by an in- 
creased affinity of the receptor for DNA or by a 
decrease in its sedimentation coefficient. 
Abbreviations: dexamethasone, 9cr-fluoro-lti-methyl- 
1 lp,l7,21-trihydroxy-l,4-pregnadiene-3,20-dione;HTC, 
hepatoma tissue culture; Tricine, N-[2-hydroxy-l,l-his- 
(hydroxymethyl)ethyl]giycine 
Earlier studies have suggested that the non- 
transformed receptor may be associated with 
RNA. Treatment of the cytosolic receptor with 
ribonuclease stimulated its tr~sformation [2,3]; 
this was inhibited by cytosolic RNA [2,4] and by 
molybdate [3]. In view of this indirect evidence and 
of the suggestion [l] that this effect of ribonuclease 
is an artifact, we have approached the question in 
a more direct way. We show here that the non- 
transformed receptor of rat hepatoma (HTC) cells, 
which possess teroid receptors for glucocorticoids 
only 151, behaves as a ribonucleoprotein after 
crosslinking in vitro and in vivo. 
2. MATERIALS AND METHODS 
2.1. ~ff~erials 
Reagent grade materials were used in all ex- 
periments, [3H]Dexamethasone (41 Ci/mmol) was 
from the Radiochemical Centre, Amersham, UK; 
[3H]dexamethasone 21-mesylate (49 Ci/mmol), 
and [14C]uridine (50 Ci/mmol) from New England 
Nuclear, Boston, MA. Dexamethasone and dex- 
amethasone mesylate were gifts from Merck, 
Sharp and Dohme (Rahway, NJ) and Dr M.V. 
Govindan, respectively. Ribonuclease A was from 
~b~~~~d by Eisevier Science ~bij~~~rs 8. V. ~Bio~ed~~u~ iv~ion~ 
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Boehringer, Mannheim, FRG; it was pretreated at 
80°C for 20 min to destroy deoxyribonuclease and 
protease activity. CsCl was from Bethesda 
Research Laboratory, Gaithersburg, MD. The M, 
markers, phosphorylase b, aldolase, serum 
albumin, ovalbumin and myoglobin were from 
SERVA, Heidelberg, FRG or from Pharmacia, 
Uppsala, Sweden. Buffer A contained 20 mM 
Tricine (Calbiochem, San Diego, CA), 10 mM 
NazMoOd, and 1 mM EDTA (pH 7.4). 
2.2. Cell culture and labeling procedures 
HTC cells (clone 4) were grown in suspension 
culture and used in the logarithmic phase of 
growth, and cytosol was prepared in buffer A [6]. 
RNA was labeled by incubating the cells in 
presence of [14C]uridine (3 &i/ml) for 20 h at 
37°C. The receptor was labeled noncovalently by 
incubating cytosol with 25 nM [3H]dexamethasone 
for 2-4 h at 4°C. Bound receptor concentration 
was determined by a charcoal adsorption assay [6]. 
The receptor was labeled covalently either by 
adding [3H]dexamethasone mesylate (80 nM) to 
the cell culture medium 30 min before harvesting 
the cells [7], or by incubating the cytosol with 
50 nM of this steroid for 4 h at 4°C. 
2.3. Gradients 
Sucrose and CsCl gradient centrifugations were 
performed in a Beckman (Palo Alto, CA) L3-50 
ultracentrifuge using a SW50.1 rotor. Linear 
sucrose (5-20%, w/v) gradients in buffer A were 
layered with 0.25 ml cytosol and centrifuged at 
39000 rpm for 16 h at 4°C. Fractions (0.14 ml) 
were collected, lo-,J aliquots were made 10% 
(w/v) with trichloroacetic acid at 4°C and the 
precipitate collected on glass fiber filters. Radioac- 
tivity was measured in a Ready-solv (Beckman) 
scintillation mixture using a Beckman LS 1800 
counter. For CsCl gradients, cytosol or pooled 
fractions from sucrose gradients were dialysed at 
4°C for 4 h against a 10 mM sodium phosphate 
buffer, pH 7.0 and for 24 h against the same buf- 
fer containing 2% (v/v) formaldehyde. The 
dialysate was mixed with CsCl crystals to give a 
density of 1.5 g/cm3. After isopycnic centrifuga- 
tion (44000 rpm at 22°C for 90 h) 0.16 ml frac- 
tions were collected, their density was determined 
by pycnometry of 10 ~1 aliquots, and the radioac- 
48 
tivity in the acid-precipitable material was 
measured as described for sucrose gradients. 
2.4. Other methods 
Photochemical RNA-protein crosslinking in in- 
tact cells was carried out as described earlier [S]. 
The cells at a density of lO’/ml (3 ml per 50-mm 
Petri dish on ice) were irradiated for 15 min at 
3.6 x lo5 erg/mm’ using two Philips TUV15W 
ultraviolet lamps. Cytosol prepared in buffer A 
was incubated with ribonuclease A (200 pg/ml) for 
30 min at 37°C [9], and concentrated by 
trichloroacetic acid precipitation [7] for 
SDS-polyacrylamide gel electrophoresis (PAGE) 
[IO]. 
3. RESULTS AND DISCUSSION 
In a first series of experiments, the cytosol was 
incubated with the electrophilic ligand dex- 
1 
IO 20 30 
FRACTION NUMBER 
Isopycnic CsCl centrifugation radioactivity 
profile of cytosol labeled with [‘Hldexamethasone 
mesylate, treated (A) or not (0) with ribonuclease, and 
then crosslinked with formaldehyde. Radioactivity in the 
fractions was determined by acid precipitation and 
collection on filters as described in section 2. Lozenges 
and numbers in the figure refer to density. 
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amethasone mesylate to label the receptor 
covalently [ 111, and treated with formaldehyde so 
that putative receptor-RNA complexes are stabi- 
lized by chemical crosslinking [ 12- 151. The cytosol 
was then analysed in CsCl gradients under condi- 
tions that allow detection of complexes between 
proteins and nuclear or cytoplasmic RNA [ 12- 151. 
In such gradients, proteins band at 1.25 g/cm3, 
hnRNA- and mRNA-protein complexes at 
1.40 g/cm3, ribosomes at 1.50-1.57 g/cm3, and 
free RNA sediments at the bottom of the tube 
(1.9 g/cm3). Data in fig. 1 show that acid-insoluble 
radioactivity, which presumably includes that 
associated with the receptor, displayed a 
heterogeneous profile with peaks at 1.37 and 
1.30-1.34 g/cm3. Treatment of the cytosol with 
1 mg/ml ribonuclease A (4”C, 60 min) prior to 
crosslinking with formaldehyde eliminated the 
r 
peak at 1.37 g/cm3. Thus, some of the material 
labeled with dexamethasone mesylate behaved as a 
ribonucleoprotein rather than as a free protein. 
Since dexamethasone mesylate binds nonspe- 
cifically to proteins other than the receptor, the 
latter was partially purified by centrifuging the 
covalently labeled cytosol on a sucrose gradient 
prior to crosslinking. At the low ionic strength 
used, the nontransformed receptor labelled with 
[3H]dexamethasone sedimented essentially as a 
single peak at 8-9 S (fig.2A). When the label was 
dexamethasone mesylate this peak was still present, 
with an additional peak at 4 S. A parallel experi- 
ment using cytosol incubated with competing non- 
radioactive steroid showed that the 4 S peak con- 
tained mainly proteins that bind the steroid non- 
specifically, together with receptor presumably in 
the transformed conformation (fig.2B). Fractions 
B 
FRACTION NUMBER 
Fig.2. Sedimentation velocity profile, after centrifugation on S-20% sucrose gradients, of cytosol labeled with 
[3H]dexamethasone (A) or [3H]dexamethasone mesylate (B) in the absence (0) or presence (A) of 200-fold excess 
competing nonradioactive steroid. Prior to counting the fractions, free steroid was eliminated either by charcoal 
adsorption (A) or by acid-precipitation on filters (B). Note the difference in scale between panels A and B. A4, markers 
were aldolase, serum albumin, and myoglobin. Fractions under the horizontal bars in B were pooled for the experiment 
shown in fig.3. 
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from the 4 s a& 8-9 s regions of the gradient 
~ontai~i~g material fabefed with r3H~dexametba- 
sane mesytate were pooled, crosslinked with for- 
maldehyde, and equiiibrated in CsCl gradients. 
The radioactivity profiles (fig.31 show that the 
material under the 4 S peak of t.he sucrose gradient 
equilibrated with the free proteins at 1.28 g/cm3, 
while the nontransformed receptor banded at 
1.37 g/cm3, and with a better resolution than when 
using unpurified cytosol (see fig, i). The 
ribon~c~eo~rote~n nature of the material banding 
at I.37 g/cm’ was further supported by the fact 
that prior ribonucfease treatment shifted its density 
to I.28 g/cm3 (not shown). ft is aiso supported by 
the data shown in fig.4. In this experiment, stabie 
RNA was labeled by growing the cells in the 
presence of [14C]uridine, following which the 
cytosol prepared from these cells WM incubated 
with ]sH]dexamethasone mesylate to label the 
receptor. Sucrose gradient analysis of’ the cytosoI 
showed the expected two peaks of macromolecule- 
bound steroid and a broad profile of uridine- 
labeled material. CsCI analysis of the crosshnked 
pooled fractions under the 8-9 S peak again 
showed a band of macro~o~ecu~e~bound dex- 
amethasone mesyiate at 1.37 g/c&, now coin- 
ciding with a minor RNA peak. The rest of the 
“r 
-_-.L 
a IO 20 30 
FRACTION NUMBER 
-J 
F”iig.3. hopycnic CsCl ce~trif~~~t~o~ ~adioact~v~~ 
profife of poofed fractiom under the 8 S (*) or the 4 S 
(h) peaks of the gradient shown in fig.ZB. The pooled 
fractions were diaiysed, cross-linked, and prepared for 
ce~t~~fu~at~o~ as described i~ section 2, For other 
details, see fig.1. were identical to those in fig.3. 
Fig.4. (A) Sedimentation velocity profile, after 
centrifugation on 4-209’0 sucrose gradients, of dauble- 
labeled cytosal. RNA was labeled in vivo by incubating 
the cells with f”4C]uridine (0) and the receptor was 
labeled in vitro by incubating the cytosot with 
~~~de~am~t~aso~e mesytate (rf. FOE other details, see 
Eg.2B. @3) rsopycnic CsCI ce~tr~~~~at~on pr file of the 
poded sucrose gradient fractions co~res~o~diu~ ta the 
8 S receptor peak in panei A. Experimental ~o~d~t~ons 
LETTERS February f 985 
RNA either formed other complexes (1.40 @cm’) 
or sedimented at the bottom of the tube. 
-- _-- 
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Because RNA may associate artifactually with 
proteins in vitro [16,17], an experiment was de- 
signed to try and detect receptor-RNA complexes 
that could occur in vivo. When intact cells are ir- 
radiated at 254 nm, protein and RNA molecules in 
direct contact can become photochemically 
crosslinked [8]. RNA and the receptor were now 
labelled in intact cells by incubating them with 
[14C]uridine and [3H]dexamethasone mesylate and 
the cells were irradiated as described in section 2. 
Cytosol was prepared, treated with ribonuclease, 
and the proteins analysed by SDS-PAGE. In such 
gels, the receptor migrates with an apparent Mr 
around ~~~ [7]. Any protein that was in contact 
with the labeled RNA at the time of irradiation is 
expected to carry [‘4C]uridine-labeled ribonucleo- 
tides left over after RNA digestion [lSf . The elec- 
trophoretic profile (fig.5) shows that one of these 
proteins migrated where the receptor is expected to 
94K 67K 43K 
+ + + 
r 74 
t f 5 I ’ lo 
IO 20 30 40 50 
SLICE NUMBER 
Fig.5. SDS-PAGE of proteins crosslinked to nucleic 
acids in vivo. The receptor and RNA were both labeled 
in intact cells as described in section 2 using 
[3H]dexamethasone mesylate (0) and [‘4C]uridine (o), 
respectively. The cells were irradiated as described, the 
cytosol was treated with ribonuclease, concentrated by 
precipitation with trichloroacetic acid, resuspended in 
sample buffer, and analysed on a 10% polyacrylamide 
slab gel. After fixation with acetic acid and methanol, 
the gel was cut into 1.2-mm slices which were dissolved 
in Hz02 and counted for radioactivity. A 
SuperimposabIe profile was found in a parallel 
experiment using [3H]uridine to increase the labeling of 
RNA. I%& markers were phosphorylase 6, serum 
albumin, and ovalbumin (arrows). 
do so, and that it was labeled with the steroid 
iigand. 
Taken together, these results provide direct 
evidence for a possible association between the 
glucocorticoid receptor found in the cytosol of 
HTC cells and an RNA. The physiological 
significance of this finding is not known. Such an 
RNA could maintain the receptor in the non- 
transformed state by ‘covering’ the DNA-binding, 
or another, site on the receptor. This must be 
reconciled with the fact that nuclear glucocorti- 
coid-receptor complexes are also sensitive to 
ribonuclease treatment [19,20]. However, nuclear- 
bound steroid receptors might occur in the non- 
transformed state [21]. A receptor-associated RNA 
also could allow receptor translocation across the 
nuclear membrane, in the same way as the RNA- 
containing ‘signal recognition particle’ participates 
to injection of secretory proteins into the en- 
doplasmic reticulum [22]. Another possibility is 
that DNA recognition by the receptor involves a 
receptor-associated RNA molecule. Alternatively, 
such an RNA might play a role in the post-trans- 
criptional effects of the receptor. Clarification of 
these speculative but exciting issues (small RNAs 
can behave as biochemical catalysts, see [23]) re- 
quires characterization of this RNA, a work in 
progress in our laboratory. 
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